Canadian society of transplantation consensus workshop on cytomegalovirus management in solid organ transplantation final report.
The Canadian Society of Transplantation sponsored a Cytomegalovirus (CMV) Consensus Working Group that met on March 19, 2003. The objectives of this group were to determine the current burden of CMV-associated disease in the setting of solid organ transplantation in Canada, make recommendations regarding optimal strategies for the diagnosis, treatment and prevention of CMV infection and disease, highlight gaps in knowledge and outline priorities for research and other initiatives that might further reduce the burden of CMV-associated effects in this setting. This report summarizes the recommendations of the working group including ratings of the strength of evidence supporting the recommendations.
Preiksaitis
Jutta K
JK
Provincial Laboratory for Public Health (Microbiology), University of Alberta, Edmonton, Alberta, Canada. j.preiksaitis@provlab.ab.ca
Brennan
Daniel C
DC
Fishman
Jay
J
Allen
Upton
U
D000998:Antiviral Agents / Q000494:pharmacology; D002170:Canada; D003587:Cytomegalovirus / Q000187:drug effects; D003586:Cytomegalovirus Infections / Q000188:drug therapy / Q000517:prevention & control; D015774:Ganciclovir / Q000494:pharmacology; D006801:Humans; D016377:Organ Transplantation
D000998:Antiviral Agents; D015774:Ganciclovir